TY - JOUR
T1 - Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG)
AU - Conconi, Annarita
AU - Janikova, Andrea
AU - Vannata, Barbara
AU - Ramírez‐Ibarguen, Ana Florencia
AU - Lobetti‐Bodoni, Chiara
AU - Belada, David
AU - Pirosa, Maria Cristina
AU - Mian, Michael
AU - Ferreri, Andrés J. M.
AU - Ryan, Gail
AU - Pangalis, Gerassimos
AU - Cabrera, Maria Elena
AU - Luminari, Stefano
AU - Montoto, Silvia
AU - Tsang, Richard
AU - Aurer, Igor
AU - Visco, Carlo
AU - Casaluci, Gloria Margiotta
AU - Prochazka, Vit
AU - Hricko, Samuel
AU - Stathis, Anastasios
AU - Mazzucchelli, Luca
AU - Ponzoni, Maurilio
AU - Federico, Massimo
AU - GAIDANO, Gianluca
AU - Lopez‐Guillermo, Armando
AU - Pro, Barbara
AU - Rossi, Davide
AU - Cascione, Luciano
AU - Nowakowsky, Grzegorz
AU - Trneny, Marek
AU - Zucca, Emanuele
PY - 2025
Y1 - 2025
N2 - The characteristics at diagnosis and clinical course of primary extranodal follicular lymphoma (EFL) have not been extensively described. The International Extranodal Lymphoma Study Group (IELSG) conducted an international retrospective survey aimed to describe the clinical features at diagnosis and the outcomes of FL cases with a clinically dominant extranodal component. The dataset included 605 pathologically reviewed cases from 19 different countries, and their outcomes were compared to those of nodal follicular lymphomas. The two most common presentation sites for EFL were the skin (n = 334) and the gastrointestinal tract (n = 72), with 22 cases having primary duodenal localization. These subsets exhibited unique features at diagnosis and significantly different overall survival (OS) patterns. After a median follow-up of 5.5 years, primary cutaneous lymphomas showed a superior outcome [10-year OS: 89% (95% CI, 83%–93%)], while primary gastrointestinal lymphomas had an intermediate outcome [10-year OS: 79% (95% CI, 59%–90%)]. Among the gastrointestinal lymphomas, primary duodenal lymphomas tended toward the best outcome [10-year OS: 95% (95% CI, 69%–99%)]. Other primary extranodal sites had inferior outcomes [10-year OS: 59% (95% CI, 48%–68%)], similar to primary nodal lymphomas [10-year OS: 57% (95% CI, 49%–64%)]. These findings support the identification of specific primary FL localizations as distinct entities with particular clinical and biological characteristics.
AB - The characteristics at diagnosis and clinical course of primary extranodal follicular lymphoma (EFL) have not been extensively described. The International Extranodal Lymphoma Study Group (IELSG) conducted an international retrospective survey aimed to describe the clinical features at diagnosis and the outcomes of FL cases with a clinically dominant extranodal component. The dataset included 605 pathologically reviewed cases from 19 different countries, and their outcomes were compared to those of nodal follicular lymphomas. The two most common presentation sites for EFL were the skin (n = 334) and the gastrointestinal tract (n = 72), with 22 cases having primary duodenal localization. These subsets exhibited unique features at diagnosis and significantly different overall survival (OS) patterns. After a median follow-up of 5.5 years, primary cutaneous lymphomas showed a superior outcome [10-year OS: 89% (95% CI, 83%–93%)], while primary gastrointestinal lymphomas had an intermediate outcome [10-year OS: 79% (95% CI, 59%–90%)]. Among the gastrointestinal lymphomas, primary duodenal lymphomas tended toward the best outcome [10-year OS: 95% (95% CI, 69%–99%)]. Other primary extranodal sites had inferior outcomes [10-year OS: 59% (95% CI, 48%–68%)], similar to primary nodal lymphomas [10-year OS: 57% (95% CI, 49%–64%)]. These findings support the identification of specific primary FL localizations as distinct entities with particular clinical and biological characteristics.
KW - FLIPI
KW - cutaneous follicular lymphoma
KW - duodenal follicular lymphoma
KW - extranodal follicular lymphoma
KW - follicular lymphoma international prognostic Index
KW - gastrointestinal follicular lymphoma
KW - FLIPI
KW - cutaneous follicular lymphoma
KW - duodenal follicular lymphoma
KW - extranodal follicular lymphoma
KW - follicular lymphoma international prognostic Index
KW - gastrointestinal follicular lymphoma
UR - https://iris.uniupo.it/handle/11579/221668
U2 - 10.1002/hon.70111
DO - 10.1002/hon.70111
M3 - Article
SN - 0278-0232
VL - 43
JO - Hematological Oncology
JF - Hematological Oncology
IS - 4
ER -